Glutethimide
Back to searchMolecule Structure
Scientific Name
Glutethimide
Description of the Drug
Not Available
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB01437
http://www.drugbank.ca/drugs/DB01437
Brand Name(s)
Doriden, Glutethimide
Company Owner(s)
Ucb Inc, Vitarine Pharmaceuticals Inc, Halsey Drug Co Inc, Watson Laboratories Inc, Upsher Smith Laboratories Llc, Lannett Co Inc, Sanofi Aventis Us Llc
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| GABA-A receptor; anion channel | PROTEIN COMPLEX GROUP | POSITIVE MODULATOR | CHEMBL2093872 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL113708 |
| PharmGKB | PA164749505 |
| Human Metabolome Database | HMDB0015505 |
| DrugBank | DB01437 |
| PubChem: Thomson Pharma | 15414774 |
| PubChem | 3487 |
| Nikkaji | J1.475C |
| EPA CompTox Dashboard | DTXSID1023102 |
| DrugCentral | 1313 |
| Brenda | 93511 |
| Guide to Pharmacology | 7192 |
| rxnorm | GLUTETHIMIDE |
| KEGG Ligand | C07489 |
| ChEBI | 5439 |
